Chronic Constipation is a Real Medical Condition

Exercising and changing your diet can help with constipation symptoms. Over-the-counter treatments like laxatives may also help. But if your constipation keeps coming back, it could be a medical condition that may need a prescription treatment. It may be time to talk to your doctor.

Answer two quick questions to help you talk to your doctor about the types of chronic constipation.

  1. Question 1 of 2.: Do you take a prescription opioid medicine?

Take the first step by talking to your doctor about your symptoms.

Irritable Bowel Syndrome with Constipation

Constipation may be a problem for people with Irritable Bowel Syndrome. This condition is known as Irritable Bowel Syndrome with Constipation, or IBS-C. Some symptoms of IBS-C include stomach (abdominal) pain, stomach (abdominal) discomfort, and hard stools. See 'Symptoms of IBS-C' for additional information.

SEE HOW AMITIZA CAN HELP TREAT IBS-C IN WOMEN ≥ 18 YEARS

Symptoms of IBS-C

The symptoms of IBS-C can be different for everyone. Talk to your doctor if you have experienced the following for the last 3 months with symptoms starting at least 6 months ago:

  • Recurring abdominal pain at least 1 day a week in the past 3 months associated with 2 or more of the following:
    • Improvement with a bowel movement
    • Changes in the number of bowel movements
    • Changes in stool appearance
  • Hard or lumpy stools at least 25% of the time and loose or watery stools in less than 25% of bowel movements (without the use of anti-diarrhea medications or laxatives)

It’s important to describe your symptoms accurately to your doctor so they can make the correct diagnosis.

TRACK YOUR CHRONIC CONSTIPATION SYMPTOMS

What causes IBS-C?

While the causes of Irritable Bowel Syndrome with Constipation (IBS-C) are unknown, researchers think that people who suffer from it may have a colon or large intestine that is particularly sensitive to certain food and stress "triggers."

Some common triggers may include:

  • Large meals
  • Certain medicines
  • Fatty or fried foods
  • Foods like wheat, rye, barley, chocolate, milk products, or alcohol
  • Caffeinated or carbonated drinks like colas, coffee, or tea
  • Stress, conflict, or other strong emotions

GET MORE INFORMATION ON MANAGING IBS-C

“I can’t believe I waited to talk to my doctor…it was pretty motivating to finally give my problem a name.”
- Suzanne

Individual results may vary.

Suzanne, a woman with IBS-C
WATCH SUZANNE’S EXPERIENCE WITH IBS-C
Talk to your doctor

Talking to your doctor

Discussing your symptoms may seem too personal—but chronic constipation symptoms can mean you have a medical condition, and talking about it with your doctor may help you get the treatment you need.

GET HELP STARTING THE CONVERSATION
Eligible patients pay as little as $0 for AMITIZA (lubiprostone)

Pay as little as $0 for AMITIZA

Subject to maximum benefit.
You must meet Eligibility Requirements.

Register for an AMITIZA Savings Card to save on prescriptions and refills.

You’ll also receive tips and information about managing your condition.

START SAVING
Pill bottle

Taking AMITIZA

Find out what to expect when taking AMITIZA.

LEARN MORE

Uses & Important Safety Information

See More See Less

AMITIZA is used for 3 types of chronic constipation: CIC in adults, OIC in adults with chronic pain that is not caused by active cancer, and IBS-C in women ≥ 18 years. Effectiveness in patients taking methadone has not been established.

Important Safety Information

AMITIZA (lubiprostone) is not for everyone. If you know or suspect you have a bowel blockage, do not take AMITIZA. If you are unsure, your healthcare provider (HCP) should evaluate your condition before starting AMITIZA.

Some patients taking AMITIZA may experience nausea. Take AMITIZA with food and water to reduce the occurrence of nausea.

Do not take AMITIZA if you have severe diarrhea. Some patients taking AMITIZA may experience diarrhea. If your diarrhea becomes severe, stop taking AMITIZA and tell your HCP.

Patients may experience fainting and low blood pressure after taking the first dose or repeated doses of AMITIZA. Stop taking AMITIZA and tell your HCP if these reactions occur. Symptoms usually go away before the next dose but may recur with repeated use. Tell your HCP if you are taking any medications to lower blood pressure. Other side effects such as diarrhea or vomiting may increase the risk of fainting and low blood pressure.

Within an hour of taking AMITIZA, a sensation of chest tightness and shortness of breath may occur. These symptoms usually go away within three hours, but may recur with repeated use. Tell your HCP if you experience these symptoms.

The most common side effects of taking AMITIZA 24 mcg twice daily for CIC are nausea, diarrhea, headache, abdominal pain, abdominal distension, and gas. The most common side effects of taking AMITIZA 24 mcg twice daily for Opioid-Induced Constipation are nausea and diarrhea. The most common side effects of taking AMITIZA 8 mcg twice daily for IBS-C are nausea, diarrhea, and abdominal pain. These are not all the side effects associated with AMITIZA.

Tell your HCP if you are taking a diphenylheptane opioid (e.g., methadone).

AMITIZA has not been studied in pregnant women. Based on animal studies, AMITIZA may cause fetal harm. AMITIZA should only be used during pregnancy if the potential benefits justify the potential risk to the fetus. If you are pregnant or become pregnant while being treated with AMITIZA, talk to your HCP to evaluate the risks to the fetus. Tell your HCP if you are nursing and monitor infants for diarrhea.

Tell your HCP if you have liver problems.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indications

AMITIZA (lubiprostone) 24 mcg capsules twice daily is approved to treat Chronic Idiopathic Constipation (CIC) in adults. “Idiopathic” means the cause of the constipation is unknown and not due to an underlying illness or medication. AMITIZA 24 mcg twice daily is also approved to treat constipation caused by opioids, a type of prescription pain medicine, in adults with chronic pain that is not caused by active cancer. The effectiveness of AMITIZA has not been established if you are taking a diphenylheptane opioid (e.g., methadone). AMITIZA 8 mcg capsules twice daily is approved to treat Irritable Bowel Syndrome with Constipation (IBS-C) in women ≥ 18 years of age.

Please click here for complete Prescribing Information.

Get savings and support to help manage your chronic constipation.

SIGN UP FOR THE AMITIZA SAVINGS PROGRAM

[{"pageName":"cic","parentPage":"","pageURL":"/cic","pageView":"cic","pageSubview":"","pageSubviewOrder":0,"navOrder":0,"menuLabel":"cic","pageController":"StaticPage","pageAction":"StaticPage","pageTitle":"What is Chronic Idiopathic Constipation? Symptoms & Causes of\nCIC","pageDescription":"See details on the symptoms and causes of chronic idiopathic constipation (CIC). Learn about a treatment option. See Important Safety Information and Prescribing Information.","pageFloodLightURL":""},{"pageName":"oic","parentPage":"","pageURL":"/oic","pageView":"oic","pageSubview":"","pageSubviewOrder":0,"navOrder":1,"menuLabel":"oic","pageController":"StaticPage","pageAction":"StaticPage","pageTitle":"What is Opioid-Induced Constipation? Symptoms & Causes of OIC","pageDescription":"See details on the symptoms and causes of opioid-induced constipation (OIC). Learn about a treatment option. See Important Safety Information and Prescribing Information.","pageFloodLightURL":""},{"pageName":"ibs-c","parentPage":"","pageURL":"/ibs-c","pageView":"ibs-c","pageSubview":"","pageSubviewOrder":0,"navOrder":2,"menuLabel":"ibs-c","pageController":"StaticPage","pageAction":"StaticPage","pageTitle":"Irritable Bowel Syndrome with Constipation | Symptoms &\nCauses of IBS-C","pageDescription":"See details on the symptoms and causes of irritable bowel syndrome with constipation (IBS-C). Learn about a treatment option. See Important Safety Information and Prescribing Information.","pageFloodLightURL":""}]